본문 바로가기
KERD
논문KCI 등재

Trends in Stroke Presentations before and during the COVID-19 Pandemic: A Meta-Analysis

Khurshid Khan|Noman Ishaque|Asif Javed Butt|Joseph Kamtchum-Tatuene|Ali Zohair Nomani|Sarah Razzaq|Nida Fatima|Chetan Vekhande|Radhika Nair|Naveed Akhtar|Maher Saqqur|Ashfaq Shuaib
대한뇌졸중학회 (The Korean Stroke Society)|2022.01|대한뇌졸중영문학회지 (Journal of stroke)|제24권 제1호|pp. 65-78|DOI 10.5853/jos.2021.01571

0

조회

0

다운로드

1

인용

0

참고문헌

키워드

COVID-19Meta-analysisStrokeHospitalizationThrombectomyFibrinolysis
주제분류신경과학

초록

Background and Purpose There are reports of decline in the rates of acute emergency presentations during coronavirus disease 2019 (COVID-19) pandemic including stroke. We performed a meta-analysis of the impact of COVID-19 pandemic on rates of stroke presentations and on rates of reperfusion therapy. Methods Following the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines, we systematically searched the literature for studies reporting changes in stroke presentations and treatment rates before and during the COVID-19 pandemic. Aggregated data were pooled using meta-analysis with random-effect models. Results We identified 37 observational studies (n=375,657). Pooled analysis showed decline in rates of all strokes (26.0%; 95% confidence interval [CI], 22.4 to 29.7) and its subtypes; ischemic (25.3%; 95% CI, 21.0 to 30.0), hemorrhagic (27.6%; 95% CI, 20.4 to 35.5), transient ischemic attacks (41.9%; 95% CI, 34.8 to 49.3), and stroke mimics (45.6%; 95% CI, 33.5 to 58.0)during months of pandemic compared with the pre-pandemic period. The decline was most evident for mild symptoms (40% mild vs. 25%–29% moderate/severe). Although rates of intravenous thrombolytic (IVT) and endovascular thrombectomy (EVT) decreased during pandemic, the likelihood of being treated with IVT and EVT did not differ between the two periods, both in primary and in comprehensive stroke centers (odds ratio [OR], 1.08; 95% CI, 0.94 to 1.24 and OR,0.95; 95% CI, 0.83 to 1.09, respectively). Conclusions Rates of all strokes types decreased significantly during pandemic. It is of paramount importance that general population should be educated to seek medical care immediately for stroke-like symptoms during COVID-19 pandemic. Whether delay in initiation of secondary prevention would affect eventual stroke outcomes in the long run needs further study.

Abstract

Background and Purpose There are reports of decline in the rates of acute emergency presentations during coronavirus disease 2019 (COVID-19) pandemic including stroke. We performed a meta-analysis of the impact of COVID-19 pandemic on rates of stroke presentations and on rates of reperfusion therapy. Methods Following the Meta-analysis Of Observational Studies in Epidemiology (MOOSE) guidelines, we systematically searched the literature for studies reporting changes in stroke presentations and treatment rates before and during the COVID-19 pandemic. Aggregated data were pooled using meta-analysis with random-effect models. Results We identified 37 observational studies (n=375,657). Pooled analysis showed decline in rates of all strokes (26.0%; 95% confidence interval [CI], 22.4 to 29.7) and its subtypes; ischemic (25.3%; 95% CI, 21.0 to 30.0), hemorrhagic (27.6%; 95% CI, 20.4 to 35.5), transient ischemic attacks (41.9%; 95% CI, 34.8 to 49.3), and stroke mimics (45.6%; 95% CI, 33.5 to 58.0)during months of pandemic compared with the pre-pandemic period. The decline was most evident for mild symptoms (40% mild vs. 25%–29% moderate/severe). Although rates of intravenous thrombolytic (IVT) and endovascular thrombectomy (EVT) decreased during pandemic, the likelihood of being treated with IVT and EVT did not differ between the two periods, both in primary and in comprehensive stroke centers (odds ratio [OR], 1.08; 95% CI, 0.94 to 1.24 and OR,0.95; 95% CI, 0.83 to 1.09, respectively). Conclusions Rates of all strokes types decreased significantly during pandemic. It is of paramount importance that general population should be educated to seek medical care immediately for stroke-like symptoms during COVID-19 pandemic. Whether delay in initiation of secondary prevention would affect eventual stroke outcomes in the long run needs further study.

참고문헌 (78)

  1. Zhu N, "A novel coronavirus from patients with pneumonia in China, 2019", N Engl J Med, 382, pp.727~733 (2020)
  2. "WHO Director-General’s opening remarks at the media briefing on COVID19" (2020)[URL]
  3. Mafham MM, "COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England", Lancet, 396, pp.381~389 (2020)
  4. Schwarz V, "Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19", Clin Res Cardiol, 109, pp.1500~1506 (2020)
  5. Butt AA, "Hospital admission rates, length of stay, and in-hospital mortality for common acute care conditions in COVID-19 vs. pre-COVID-19 era", Public Health, 189, pp.6~11 (2020)
  6. Kuitunen I, "The effect of national lockdown due to COVID-19 on emergency department visits", Scand J Trauma Resusc Emerg Med, 28, pp.114~ (2020)
  7. Oxley TJ, "Large-vessel stroke as a presenting feature of COVID-19 in the young", N Engl J Med, 382, pp.e60~ (2020)
  8. Akhtar N, "Impact of COVID-19 pandemic on stroke admissions in Qatar", BMJ Neurol Open, 3, pp.e000084~ (2021)
  9. M Mehrpour, "Coronavirus disease 2019 and stroke in Iran: a case series and effects on stroke admissions", International Journal of Stroke, 16(9), pp.1047~1052 (2020), SAGE Publications[DOI]
  10. Aguiar de Sousa D, "The curious case of the missing strokes during the COVID-19 pandemic", Stroke, 51, pp.1921~1923 (2020)
  11. Padmanabhan N, "Impact of COVID-19 on stroke admissions, treatments, and outcomes at a comprehensive stroke centre in the United Kingdom", Neurol Sci, 42, pp.15~20 (2021)
  12. Uchino K, "Decline in stroke presentations during COVID-19surge", Stroke, 51, pp.2544~2547 (2020)
  13. Perry R, "What has caused the fall in stroke admissions during the COVID-19 pandemic", J Neurol, 267, pp.3457~3458 (2020)
  14. Rudilosso S, "Acute stroke care is at risk in the era of COVID-19 : experience at a comprehensive stroke center in Barcelona", Stroke, 51, pp.1991~1995 (2020)
  15. D’Anna L, "Decreasing referrals to transient ischaemic attack clinics during the COVID-19 outbreak : results from a multicentre cross-sectional survey", BMJ Open, 10, pp.e041514~ (2020)
  16. Butt JH, "Effect of COVID-19 on first-time acute stroke and transient ischemic attack admission rates and prognosis in Denmark : a nationwide cohort study", Circulation, 142, pp.1227~1229 (2020)
  17. Kansagra AP, "Collateral effect of COVID-19 on stroke evaluation in the United States", N Engl J Med, 383, pp.400~401 (2020)
  18. Bres Bullrich M, "COVID-19: stroke admissions, emergency department visits, and prevention clinic referrals", Can J Neurol Sci, 47, pp.693~696 (2020)
  19. 김영대, "Care Process of Recanalization Therapy for Acute Stroke during the COVID-19 Outbreak in South Korea", Journal of Clinical Neurology, 17(1), pp.63~69 (2021), 대한신경과학회
  20. Pasarikovski CR, "The impact of the COVID-19pandemic on stroke volume", Can J Neurol Sci, 47, pp.847~848 (2020)
  21. Diegoli H, "Decrease in hospital admissions for transient ischemic attack, mild, and moderate stroke during the COVID-19 era", Stroke, 51, pp.2315~2321 (2020)
  22. Schlachetzki F, "Decline and recurrence of stroke consultations during the COVID-19 pandemic lockdown parallels population activity levels", Cerebrovasc Dis, 50, pp.317~325 (2021)
  23. Kato A, "Physical exertion as a trigger of acute coronary syndrome caused by plaque erosion", J Thromb Thrombolysis, 49, pp.377~385 (2020)
  24. Grau AJ, "Common infections and the risk of stroke", Nat Rev Neurol, 6, pp.681~694 (2010)
  25. Page MJ, "The PRISMA 2020 statement : an updated guideline for reporting systematic reviews", BMJ, 372, pp.n71~ (2021)
  26. "The Newcastle Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses" (2021)[URL]
  27. Sean McGrath, "Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis", Statistical Methods in Medical Research, 29(9), pp.2520~2537 (2020), SAGE Publications[DOI]
  28. Balestrino M, "Request of hospital care dropped for TIA but remained stable for stroke during COVID-19 pandemic at a large Italian university hospital", Intern Emerg Med, 16, pp.735~739 (2021)
  29. Balucani C, "Exploring the collateral damage of the COVID-19 pandemic on stroke care : a statewide analysis", Stroke, 52, pp.1822~1825 (2021)
  30. Brunetti V, "Effect of the COVID-19 pandemic and the lockdown measures on the local stroke network", Neurol Sci, 42, pp.1237~1245 (2021)
  31. Desai SM, "Collateral damage : impact of a pandemic on stroke emergency services", J Stroke Cerebrovasc Dis, 29, pp.104988~ (2020)
  32. Esenwa C, "The effect of COVID-19on stroke hospitalizations in New York City", J Stroke Cerebrovasc Dis, 29, pp.105114~ (2020)
  33. Gdovinová Z, "The impact of the COVID-19 outbreak on acute stroke care in Slovakia : data from across the country", Eur J Neurol, 28, pp.3263~3266 (2021)
  34. Hasan AT, "Impact of COVID-19 on hospital admission of acute stroke patients in Bangladesh", PLoS One, 16, pp.e0240385~ (2021)
  35. de Havenon A, "A rapid decrease in stroke, acute coronary syndrome, and corresponding interventions at 65 United States hospitals following emergence of COVID-19", medRxiv, ~ (2020)
  36. Kim TJ, "Modification of acute stroke pathway in Korea after the coronavirus disease 2019 outbreak", Front Neurol, 11, pp.597785~ (2020)
  37. Kristoffersen ES, "Effect of COVID-19 pandemic on stroke admission rates in a Norwegian population", Acta Neurol Scand, 142, pp.632~636 (2020)
  38. Kwan J, "Impact of COVID-19 pandemic on a regional stroke thrombectomy service in the United Kingdom", Cerebrovasc Dis, 50, pp.178~184 (2021)
  39. Ramírez-Moreno JM, "Slump in hospital admissions for stroke, a fact of an uncertain nature that requires explanation", Brain Sci, 11, pp.92~ (2021)
  40. Nogueira RG, "Global impact of COVID-19 on stroke care and IV thrombolysis", Neurology, 96, pp.e2824~e2838 (2021)
  41. Ortega-Gutierrez S, "Decline in mild stroke presentations and intravenous thrombolysis during the COVID-19 pandemic : the Society of Vascular and Interventional Neurology Multicenter Collaboration", Clin Neurol Neurosurg, 201, pp.106436~ (2021)
  42. Pandey AS, "Letter : COVID-19 pandemic : the Bystander effect on stroke care in Michigan", Neurosurgery, 87, pp.E397~E399 (2020)
  43. Richter D, "Analysis of nationwide stroke patient care in times of COVID-19 pandemic in Germany", Stroke, 52, pp.716~721 (2021)
  44. Rinkel LA, "Impact of the COVID-19 outbreak on acute stroke care", J Neurol, 268, pp.403~408 (2021)
  45. Sacco S, "Reduced admissions for cerebrovascular events during COVID-19 outbreak in Italy", Stroke, 51, pp.3746~3750 (2020)
  46. Sharma M, "Decline in stroke alerts and hospitalisations during the COVID-19 pandemic", Stroke Vasc Neurol, 5, pp.403~405 (2020)
  47. Słowik A, "Significant fall in stroke admissions in the Malopolska Voivodeship of Poland during the COVID-19 pandemic", Neurol Neurochir Pol, 54, pp.471~472 (2020)
  48. Tavanaei R, "Changed pattern of hospital admission in stroke during COVID-19 pandemic period in Iran : a retrospective study", Neurol Sci, 42, pp.445~453 (2021)
  49. Mag Uidhir F, "Impact of COVID-19 on stroke caseload in a major hyperacute stroke unit", J Stroke Cerebrovasc Dis, 29, pp.105383~ (2020)
  50. Uphaus T, "Stroke care within the COVID-19 pandemic-increasing awareness of transient and mild stroke symptoms needed", Front Neurol, 11, pp.581394~ (2020)
  51. Wang J, "The impact of COVID-19 on acute ischemic stroke admissions : analysis from a community-based tertiary care center", J Stroke Cerebrovasc Dis, 29, pp.105344~ (2020)
  52. Wu Y, "Reductions in hospital admissions and delays in acute stroke care during the pandemic of COVID-19", Front Neurol, 11, pp.584734~ (2020)
  53. Zhang LL, "Stroke care in the first affiliated hospital of Chengdu Medical College during the COVID-19 outbreak", Eur Neurol, 83, pp.630~635 (2020)
  54. Aboul Nour H, "Impact of the COVID-19 pandemic on acute stroke care, time metrics, outcomes, and racial disparities in a Southeast Michigan Health System", J Stroke Cerebrovasc Dis, 30, pp.105746~ (2021)
  55. D’Anna L, "Impact of national lockdown on the hyperacute stroke care and rapid transient ischaemic attack outpatient service in a comprehensive tertiary stroke centre during the COVID-19pandemic", Front Neurol, 12, pp.627493~ (2021)
  56. Dębiec A, "Effect of COVID-19 pandemic on stroke admissions and quality of stroke interventional treatment in Masovian Voivodeship", Neurol Neurochir Pol, 55, pp.223~226 (2021)
  57. Douiri A, "Stroke care in the United Kingdom during the COVID-19pandemic", Stroke, 52, pp.2125~2133 (2021)
  58. Jansen R, "Consequences of COVID-19 pandemic lockdown on emergency and stroke care in a German tertiary stroke center", Neurol Res Pract, 3, pp.21~ (2021)
  59. Libruder C, "Reduction in acute stroke admissions during the COVID-19 pandemic : data from a National Stroke Registry", Neuroepidemiology, 55, pp.354~360 (2021)
  60. Mariet AS, "Hospitalizations for stroke in France during the COVID-19 pandemic before, during, and after the national lockdown", Stroke, 52, pp.1362~1369 (2021)
  61. Melaika K, "Changes in prehospital stroke care and stroke mimic patterns during the COVID-19 lockdown", Int J Environ Res Public Health, 18, pp.2150~ (2021)
  62. Raymaekers V, "The impact of COVID-19 on acute stroke care in Belgium", Acta Neurol Belg, 121, pp.1251~1258 (2021)
  63. Wallace AN, "Patient characteristics and outcomes associated with decline in stroke volumes during the early COVID-19 pandemic", J Stroke Cerebrovasc Dis, 30, pp.105569~ (2021)
  64. Katsanos AH, "The impact of SARS-CoV-2 on stroke epidemiology and care : a meta-analysis", Ann Neurol, 89, pp.380~388 (2021)
  65. Nannoni S, "Stroke in COVID-19 : a systematic review and meta-analysis", Int J Stroke, 16, pp.137~149 (2021)
  66. Clerkin KJ, "COVID-19 and cardiovascular disease", Circulation, 141, pp.1648~1655 (2020)
  67. Lodigiani C, "Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy", Thromb Res, 191, pp.9~14 (2020)
  68. Matschke J, "Neuropathology of patients with COVID-19 in Germany : a post-mortem case series", Lancet Neurol, 19, pp.919~929 (2020)
  69. Wichmann D, "Autopsy findings and venous thromboembolism in patients with COVID-19 : a prospective cohort study", Ann Intern Med, 173, pp.268~277 (2020)
  70. Teo KC, "Delays in stroke onset to hospital arrival time during COVID-19", Stroke, 51, pp.2228~2231 (2020)
  71. Meyer D, "A stroke care model at an academic, comprehensive stroke center during the 2020 COVID-19 pandemic", J Stroke Cerebrovasc Dis, 29, pp.104927~ (2020)
  72. Singh S, "Impact of COVID-19 on acute coronary syndrome-related hospitalizations : a pooled analysis", Int J Cardiol Heart Vasc, 32, pp.100718~ (2021)
  73. Blecker S, "Hospitalizations for chronic disease and acute conditions in the time of COVID-19", JAMA Intern Med, 181, pp.269~271 (2021)
  74. "Nearly half of heart patients find it harder to get medical treatment in lockdown" (2020)[URL]
  75. Thanh N Nguyen, "Decline in subarachnoid haemorrhage volumes associated with the first wave of the COVID-19 pandemic", Stroke and Vascular Neurology, 6(4), pp.542~552 (2021), BMJ[DOI]
  76. Tsigkas G, "Potential relationship between lifestyle changes and incidence of hospital admissions for acute coronary syndrome during the COVID-19 lockdown", Front Cardiovasc Med, 8, pp.604374~ (2021)
  77. Versaci F, "Interplay between COVID-19, pollution, and weather features on changes in the incidence of acute coronary syndromes in early 2020", Int J Cardiol, 329, pp.251~259 (2021)
  78. Qian Z, "Assessment of risk of aneurysmal rupture in patients with normotensives, controlled hypertension, and uncontrolled hypertension", J Stroke Cerebrovasc Dis, 25, pp.1746~1752 (2016)

관련 논문AI추천

Therapeutic Trends of Cerebrovascular Disease during the COVID-19 Pandemic and Future PerspectivesJames E. Siegler, Mohamad Abdalkader, Patrik Michel, Thanh N. Nguyen대한뇌졸중학회 · 대한뇌졸중영문학회지2022 · 제24권 제2호Delays in Intracerebral Hemorrhage Management Is Associated with Hematoma Expansion and Worse Outcomes: Changes in COVID-19 Era권영섭, 김소연, 김용배, 김준형, 박근영, 박상규, 이우성, 이윤호, 이재환, 장창기, 정준호, 조광천, 한현진연세대학교의과대학 · Yonsei Medical Journal2021 · 제62권 제10호The Impact of COVID-19 on Admissions and In-hospital Mortality of Patients With Stroke in Korea: An Interrupted Time Series Analysis김도형, 장영수, 조은별, Bai Haibin, Hwang Soo-Hee, Lee Hyejin, Lee Jin Yong, Park Seowoo대한예방의학회 · 예방의학회지2025 · 제58권 제1호Effect of the Coronavirus Disease 2019 Pandemic on the Quality of Stroke Care in Stroke Units and Alternative Wards: A National Comparative AnalysisBenjamin Clissold, Bernard Yan, Brett Jones, Craig S. Anderson, Darshan Shah, Dominique A. Cadilhac, Emma K. Tod, Geoffrey Cloud, Helen Castley, Joosup Kim, Katherine Jaques, Kelvin Hill, Natasha A. Lannin, Richard I. Lindley, Sandy Middleton, Sibilah J. Breen, Steven Faux, Timothy Kleinig대한뇌졸중학회 · 대한뇌졸중영문학회지2022 · 제24권 제1호Care Process of Recanalization Therapy for Acute Stroke during the COVID-19 Outbreak in South Korea김규식, 김영대, 남효석, 박형종, 백민렬, 백장현, 서권덕, 서정화, 손성일, 유준상, 이혜선, 허준녕, 허지회, 홍정호대한신경과학회 · Journal of Clinical Neurology2021 · 제17권 제1호Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and MortalityAndreas Charidimou, Anna Czlonkowska, Anvitha Sathya, Davide Strambo, Diana Aguiar de Sousa, Hannah Lo, Hiroshi Yamagami, James E. Siegler, Jelle Demeestere, João Pedro Marto, Joseph Kwan, Liqun Zhang, Mohamad Abdalkader, Muhammad M. Qureshi, Ossama Yassin Mansour, Patrik Michel, Petra Sedova, Piers Klein, Raul G. Nogueira, Robert Mikulik, Setareh Salehi Omran, Shadi Yaghi, Soma Banerjee, Thalia S. Field, Thanh N. Nguyen, Violiza Inoa대한뇌졸중학회 · 대한뇌졸중영문학회지2022 · 제24권 제2호

이 간행물의 다른 논문 (19건)

Endovascular Thrombectomy in Patients with Intracranial Atherosclerosis: Where Are We?Jong S. Kimpp. 1-2Endovascular Treatment of Large Vessel Occlusion Strokes Due to Intracranial Atherosclerotic DiseaseFabricio Oliveira Lima, 홍지만, Raul G. Nogueira, Jin Soo Lee, Seong-Joon Lee, Francisco José Arruda Mont`Alvernepp. 3-20Hypertriglyceridemia: A Neglected Risk Factor for Ischemic Stroke?Hai-jie Liang, Qing-yi Zhang, Yi-tong Hu, Guo-qing Liu, Rong Qipp. 21-40Mechanical Thrombectomy Access for All? Challenges in Increasing Endovascular Treatment for Acute Ischemic Stroke in the United StatesCynthia B. Zevallos, Larry B. Goldstein, Arun Sharma, Santiago Ortega-Gutierrez, Bijoy K. Menon, Violiza Inoa, Jose G. Romano, Dileep R. Yavagal, Sushanth Rao Aroor, Kaiz S. Asif, Jennifer Potter-Vigpp. 41-48The Challenge of Designing Stroke Trials That Change Practice: MCID vs. Sample Size and PragmatismJohanna Ospel, Rosalie McDonough, Mayank Goyal, Marc Fisherpp. 49-56
원문 보기